Status | Study |
Recruiting |
Study Name: Shulman Fasciitis Prevalence Study in Alsace Condition: Shulman Fasciitis Date: 2016-06-16 |
Recruiting |
Study Name: Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome) Condition: Thrombotic Thrombocytopenic Purpura Congenital Thrombotic Thrombocytopenic Purpura Date: 2010-12-06 Interventions: Other: Observation No interventions planned: treatment of patients at the discretion of the treating/res |
Completed |
Study Name: A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy Condition: Debilitating Fibrosing Skin Disorders (Localised Scleroderma, Eosinophilic Fasciitis) Date: 2009-07-09 Interventions: Drug: Rituximab Mabthera, Rituximab 1000 mg I.V. |
Completed |
Study Name: Treatment With High Dose Methotrexate in Patients With Eosinophilic Fasciitis Condition: Fasciitis Date: 2007-02-28 Interventions: Drug: methotrexate methotrexate |